Metformin improves cognitive impairment in diabetic mice induced by a combination of streptozotocin and isoflurane anesthesia

References

• Ye J-S, Chen L, Lu -Y-Y, et al. Honokiol-mediated mitophagy ameliorates postoperative cognitive impairment induced by surgery/sevoflurane via inhibiting the activation of NLRP3 inflammasome in the hippocampus. Oxid Med Cell Longev. 2019;2019:8639618.
   PubMed Web of Science ®Google Scholar
• Vijay G. Correlation of the depth of anesthesia with POCD (Postoperative Cognitive Dysfunction). Anesth Analg. 2007;104:1298.
   PubMed Web of Science ®Google Scholar
• Saniova B, Drobny M, Sulaj M. Delirium and postoperative cognitive dysfunction after general anesthesia. Med Sci Monit. 2009;15:CS81–87.
   PubMed Web of Science ®Google Scholar
• Page VJ, Oglesby FC, Armstrong RA. Postoperative cognitive dysfunction. Curr Anesthesiol Rep. 2017;7:380–386.
   Google Scholar
• Biessels GJ, Kerssen A, Haan E, et al. Cognitive dysfunction and diabetes: implications for primary care. Prim Care Diabetes. 2007;1:187–193.
   PubMedGoogle Scholar
• McCrimmon R, Ryan C, Frier B. Diabetes and cognitive dysfunction. Lancet. 2012;379:2291–2299.
   PubMed Web of Science ®Google Scholar
• Zeinivand M, Nahavandi A, Zare M. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction. Inflammopharmacology. 2020;28:575–583.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhou SL, Pi LH, et al. High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: a potential molecular mechanism for diabetes-induced cognitive dysfunction. Oncotarget. 2017;8:40843–40856.
   PubMedGoogle Scholar
• Freude S, Plum L, Schnitker J, et al. Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes. 2005;54:3343–3348.
   PubMed Web of Science ®Google Scholar
• Kulstad JJ, Green PS, Cook DG, et al. Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease. Digest World Core Med J. 2006;66:1506–1510.
   Google Scholar
• Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60:1586–1593.
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15:569–589.
   PubMed Web of Science ®Google Scholar
• Brunk D. Long-term metformin use may protect against neurodegenerative disease. Caring Ages. 2016;17:3.
   Google Scholar
• Gorgich E, Parsaie H, Yarmand S, et al. Long-term administration of metformin ameliorates age-dependent oxidative stress and cognitive function in rats. Behav Brain Res. 2021;410:113343.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Wahlqvist ML, Lee MS, et al. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis Jad. 2011;24:485–493.
   PubMed Web of Science ®Google Scholar
• Cheng C, Ching-Heng L, Yi-Wen T, et al. Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. J Gerontol. 2014;69:1299–1305.
   Google Scholar
• Orkaby AR, Cho K, Cormack J, et al. Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes. Neurology. 2017;89:1877–1885.
   PubMed Web of Science ®Google Scholar
• Guo M, Mi J, Jiang Q, et al. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharmacol Physiol. 2014;41:650–656.
   PubMed Web of Science ®Google Scholar
• Zou W, Yuan J, Tang ZJ, et al. Hydrogen sulfide ameliorates cognitive dysfunction in streptozotocin-induced diabetic rats: involving suppression in hippocampal endoplasmic reticulum stress. Oncotarget. 2017;8:64203–64216.
   PubMedGoogle Scholar
• Ozdemir D, Baykara B, Aksu I, et al. Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats. Neurosci Lett. 2012;507:84–89.
   PubMed Web of Science ®Google Scholar
• Shi L, Zhang Z, Li L, et al. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model. Behav Brain Res. 2017;327:65–74.
   PubMed Web of Science ®Google Scholar
• Li T, Jiao JJ, Hölscher C, et al. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer’s disease. Hippocampus. 2018;28:358–372.
   PubMed Web of Science ®Google Scholar
• Yaffe K, Lindquist K, Schwartz AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2011;77:1351–1356.
   PubMed Web of Science ®Google Scholar
• Yang C, Zhu B, Jie D, et al. Isoflurane anesthesia aggravates cognitive impairment in streptozotocin-induced diabetic rats. Int J Clin Exp Med. 2014;7:903–910.
   PubMed Web of Science ®Google Scholar
• Lalithambika CV, Arun C, Saraswathy LA, et al. Cognitive impairment and its association with glycemic control in type 2 diabetes mellitus patients. Indian J Endocrinol Metab. 2019;23:353–356.
   PubMedGoogle Scholar
• Mimenza-Alvarado AJ, Jiménez-Castillo G, Yeverino-Castro SG, et al. Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: the Mexican Health and Aging Study. BMC Geriatr. 2020;20:424.
   PubMed Web of Science ®Google Scholar
• Han X, Tao Y-L, Deng Y-P, et al. Metformin ameliorates insulitis in STZ-induced diabetic mice. PeerJ. 2017;5:e3155.
   PubMed Web of Science ®Google Scholar
• D’Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev. 2001;36:60–90.
   PubMed Web of Science ®Google Scholar
• Squire LR, Ojemann JG, Miezin FM, et al. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci USA. 1992;89:1837–1841.
   PubMed Web of Science ®Google Scholar
• Li G, Cheng H, Zhang X, et al. Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice. Neurol Sci. 2013;34:963–969.
   PubMed Web of Science ®Google Scholar
• Hicks RR, Smith DH, Lowenstein DH, et al. Mild experimental brain injury in the rat induces cognitive deficits associated with regional neuronal loss in the hippocampus. J Neurotrauma. 1993;10:405–414.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang S, Zhang X, et al. IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation. J Neuroinflammation. 2015;12:165.
   PubMed Web of Science ®Google Scholar
• Imfeld P, Bodmer M, Jick SS, et al. Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case-control study. J Am Geriatr Soc. 2012;60:916–921.
   PubMed Web of Science ®Google Scholar
• Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab. 2016;42:316–327.
   PubMed Web of Science ®Google Scholar